February 25, 2019 at 3:44 pm
A formal claim will be made against GlaxoSmithKline by more than 20 people in the Netherlands who used Seroxat (paroxetine) in their youth. (GSK sells paroxetine as Paxil in America.) The group states GSK failed to inform them about the serious psychological side effects of the drug, including aggressive behavior and an increased risk of suicide. These adverse drug effects were apparently not listed on GSK’s Seroxat label at the time these teens were given the drug.
See: https://www.dutchnews.nl/news/2019/02/dutch-seroxat-teen-users-to-sue-drug-maker-for-side-effects/
February 21, 2019 at 2:40 pm
MISSD Board member, Kim Witzack, discusses the recent FDA approval of esketamine, a nasal spray to be marketed as an antidepressant. Witzack serves as a consumer representative on the FDA Advisory Committee. The FDA reviewed only one positive clinical trial before approving the drug.
See: https://www.madinamerica.com/2019/02/nasal-spray-for-depression/
February 19, 2019 at 1:57 pm
The Human Givens Institute provides an informative podcast with psychotherapist Marion Brown who sheds light on adverse drug effects. MISSD sincerely appreciates Brown’s reference to our work. Listen at: https://www.hgi.org.uk/resources/podcasts/why-antidepressants-need-be-understood
February 11, 2019 at 1:40 pm
February 6, 2019 at 2:52 pm
February 1, 2019 at 9:24 am
Consumers and family members should be aware of symptoms of prescription drug withdrawal, to include withdrawal akathisia, whenever stopping certain prescriptions such as SSRIs, a class of drugs commonly labeled as antidepressants.
See: psychiatrictimes.com/couch-crisis/international-antidepressant-withdrawal-crisis-time-act
January 27, 2019 at 12:12 pm
MISSD continues to be concerned about the alarming rate of suicides among veterans. Some explanations refer to combat-related PTSD, long deployments and difficulties adjusting to civilian life after returning home. However, many of these reported deaths are of young Marines who have never been deployed nor seen combat. While this article doesn’t mention prescription drugs, there is growing concern regarding possible adverse drug effects some vets may be suffering. House Bill 4640 was created to explore the relationship between prescription drugs and military suicides. Unfortunately, no action has been taken on the bill since its introduction in 2016.
MISSD strongly supports further research and funding to help reduce the staggering number of suicides in the military. Vets deserve access to quality care and informed consent regarding a variety of treatment options to include cognitive therapy. More than 20 veteran suicides are reported every day. Action is needed to develop a more comprehensive understanding regarding the causes of these alarming statistics.
January 22, 2019 at 11:15 am
MISSD is pleased to see patient safety at the forefront of public discussion. Former President Clinton and Grammy nominee Belinda Carlisle recently spoke at the World Patient Safety Summit. Carlisle states this cause is close to her heart given she has lost family and friends due to medical errors. More than 200,000 people die every year in U.S. hospitals and 4.8 million worldwide in ways that could have been prevented.
See: www.businesswire.com/news/home/20190120005015/en/President-Clinton-Powerful-Message-Attendees-World-Patient
January 17, 2019 at 1:04 pm
Efforts to mislead doctors and patients about the dangers of Purdue Pharma’s opioid product came from the top, alleges new court filing. See: nytimes.com/2019/01/15/health/sacklers-purdue-oxycontin-opioids.html
January 11, 2019 at 6:15 am
Washington’s ABC Channel 7 spotlights adverse drug effects. Drug safety advocates note kids are being given Zoloft for bed wetting, nail biting and test anxiety while many families are not informed about the risks of akathisia-induced death. See: wjla.com/features/7-on-your-side/suicide-risks-prescription-drugs?fbclid=IwAR27ukmt3fJV-of6c2wHCoFG7KcGBVBMYo1R5aPsN5UOg1PkA3YhtGULzzg